Endometrial hyperplasia
Management follows the presence or absence of atypia. Without atypia, treatment is medical with surveillance; with atypia, the risk of coexisting or later cancer changes the approach.
Suspected and confirmed malignancy: endometrial hyperplasia, ovarian masses before and after the menopause, cervical screening, gestational trophoblastic disease, and cancer in pregnancy.
10 Part 2 questions, no account needed, scored straight away.
6
RCOG, NICE and related
40/60
SBA / EMQ share of marks
Gynaecology
5 other modules
Part 2 is 200 questions across 2 papers, each 50 SBAs and 50 EMQs in three hours. SBAs carry 40% of the marks and EMQs 60%, so a module you know only well enough to recognise one best answer is still a module you can lose an EMQ theme on. The RCOG does not publish how many questions fall to gynaecological oncology, and this page does not estimate one. What it gives you instead is the published guidance the questions are written from.
Oncology questions are about triage and classification: which result needs referral, which can be observed, and how the pathway differs before and after the menopause.
Management follows the presence or absence of atypia. Without atypia, treatment is medical with surveillance; with atypia, the risk of coexisting or later cancer changes the approach.
Most are benign. The guideline sets out how ultrasound features and tumour markers are combined to decide who is referred to a specialist team.
Management of Suspected Ovarian Masses in Premenopausal Women
CA125 and ultrasound are combined into a risk score for postmenopausal women. Know which findings allow conservative follow-up and which need onward referral.
Testing for high-risk HPV is the first step, with cytology used to triage positive samples. Understand the follow-up steps for each possible result.
Pregnancy changes how breast cancer is investigated and treated, and gestational trophoblastic disease is followed with hormone monitoring and specialist input.
Pregnancy and Breast Cancer Gestational Trophoblastic Disease
Revise as a set of triage rules: for each result, who is referred urgently, who is investigated further and who is reassured. Keep the premenopausal and postmenopausal ovarian pathways side by side to see how they differ. Link every classification back to the Part 1 pathology summary so that the logic is clear.
This module builds on the Part 1 pathology area: classification there becomes triage here. Learn the classification first, and the management follows from it.
SBAs and EMQ themes, every one original and written from published RCOG and NICE guidance, with the guideline cited in the explanation so you can check the answer against the source. Free: 5 days full access, then 50 questions. No card.
The 6 published guidelines this module draws on, each summarised for revision with the source cited.
Longer reads from the blog that sit around this topic.
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).